|
|
Volumn 527, Issue 7577, 2015, Pages 146-147
|
|
Leukaemia success heralds wave of gene-editing therapies
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BLOOD CLOTTING FACTOR 9;
ZINC FINGER NUCLEASE;
CRISPR CAS SYSTEM;
DNA MODIFICATION;
GENE THERAPY;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
IMMUNOCOMPETENT CELL;
NONHUMAN;
NOTE;
PRIORITY JOURNAL;
T LYMPHOCYTE;
ANIMAL;
BETA-THALASSEMIA;
CLINICAL TRIAL (TOPIC);
FEMALE;
GENETIC ENGINEERING;
GENETICS;
HEMOGLOBINOPATHIES;
HEMOPHILIA B;
HIV INFECTIONS;
IMMUNOLOGY;
INFANT;
LEUKEMIA;
METABOLISM;
TRANSPLANTATION;
UNITED KINGDOM;
ANIMALS;
BETA-THALASSEMIA;
CLINICAL TRIALS AS TOPIC;
FACTOR IX;
FEMALE;
GENETIC ENGINEERING;
GENETIC THERAPY;
HEMOGLOBINOPATHIES;
HEMOPHILIA B;
HIV INFECTIONS;
HUMANS;
INFANT;
LEUKEMIA;
LONDON;
T-LYMPHOCYTES;
|
|
EID: 84946925920
PISSN: 00280836
EISSN: 14764687
Source Type: Journal
DOI: 10.1038/nature.2015.18737 Document Type: Note |
|
Times cited : (36)
|
|
References (0)
|